TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Laekna, Inc. ( (HK:2105) ) has issued an announcement.
Laekna, Inc. has announced a board meeting scheduled for August 13, 2025, to consider and approve the interim results for the first half of the year. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:2105) stock is a Buy with a HK$26.46 price target. To see the full list of analyst forecasts on Laekna, Inc. stock, see the HK:2105 Stock Forecast page.
More about Laekna, Inc.
Laekna, Inc. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It focuses on developing and commercializing innovative therapies, with a market emphasis on addressing unmet medical needs.
Average Trading Volume: 5,000,522
Technical Sentiment Signal: Strong Buy
Learn more about 2105 stock on TipRanks’ Stock Analysis page.